Aztreonam ethyl ester

For research use only. Not for therapeutic Use.

  • CAT Number: I022950
  • CAS Number: 102579-57-7
  • Molecular Formula: C15H21N5O8S2
  • Molecular Weight: 463.48
  • Purity: 98%
Inquiry Now

Aztreonam ethyl ester(Cat No.:I022950) is a monobactam antibiotic that is primarily employed for the treatment of infections caused by gram-negative bacteria. It exhibits bactericidal activity by inhibiting the synthesis of bacterial cell walls. Aztreonam ethyl ester is effective against a wide range of gram-negative pathogens, including Pseudomonas aeruginosa. It is administered via intravenous or intramuscular routes and is commonly used in clinical settings to treat various infections, such as urinary tract infections, respiratory tract infections, intra-abdominal infections, and sepsis caused by susceptible bacteria.


Catalog Number I022950
CAS Number 102579-57-7
Synonyms

Aztreonam ethyl ester

Molecular Formula C15H21N5O8S2
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
IUPAC Name (2S,3S)-3-((Z)-2-(2-ammoniothiazol-4-yl)-2-(((1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy)imino)acetamido)-2-methyl-4-oxoazetidine-1-sulfonate
InChI InChI=1S/C15H21N5O8S2/c1-5-27-13(23)15(3,4)28-19-10(8-6-29-14(16)17-8)11(21)18-9-7(2)20(12(9)22)30(24,25)26/h6-7,9H,5H2,1-4H3,(H2,16,17)(H,18,21)(H,24,25,26)/b19-10-/t7-,9-/m0/s1
InChIKey GHYPJWICYOYVRU-AICXJHAVSA-N
SMILES CCOC(=O)C(C)(C)ON=C(/C(=O)N[C@H]1[C@H](C)N(C1=O)S(=O)(=O)[O-])c2csc([NH3+])n2
Reference

1: Gaeta F, Valluzzi RL, Alonzi C, Maggioletti M, Caruso C, Romano A. Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol. 2015 Apr;135(4):972-6. doi: 10.1016/j.jaci.2014.10.011. Epub 2014 Nov 22. PubMed PMID: 25457154.
2: Singh R, Kim A, Tanudra MA, Harris JJ, McLaughlin RE, Patey S, O’Donnell JP, Bradford PA, Eakin AE. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam. J Antimicrob Chemother. 2015 Sep;70(9):2618-26. doi: 10.1093/jac/dkv132. Epub 2015 May 29. PubMed PMID: 26024868.
3: Schechter MS, Trueman D, Farquharson R, Higuchi K, Daines CL. Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation. Ann Am Thorac Soc. 2015 Jul;12(7):1030-8. doi: 10.1513/AnnalsATS.201312-453OC. PubMed PMID: 26053185.

Request a Quote